Description
Recombinant monoclonal antibody to CD86. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BU63. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
CD86
Target Alias Names
B7.2, T lymphocyte activation antigen CD86, Activation B7-2 antigen, B72, B7-2, CTLA-4 counter-receptor B7.2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression